Administrative Core A will manage, co-ordinate, and provide communication between the investigators in the AADCRC. Dr. Broide will continue to serve as overall Program PI of the UCSD AADCRC and manage the program through Core A in consultation with the program executive committee comprising PIs of the three individual projects (Broide, Croft, Doherty) as well as key co-investigators (Kurten, Hamid). Dr Broide will ensure that the administrative, scientific, and fiscal responsibilities of the AADCRC are carried out as proposed. Dr. Broide will be assisted by his administrative assistant Stella Tan, as well as his budget analyst Grace Pangco in the Department of Medicine Business office. Core A will organize monthly scientific meetings of the UCSD AADCRC to have formal presentations from each project and scientific core in rotation and discuss work in progress. Core A will continue to provide travel funds and ensure that Project PIs and key Core co-Investigators attend and present their work at the annual NIH AADCRC meeting in Bethesda. The two co-investigators not at UCSD in Core B (Kurten, Hamid) will participate by videoconference in the monthly meetings. Core A will prepare six monthly reviews of progress made by each Project and Core to assess how they are meeting the goals of the overall AADCRC, interaction between projects, and use of Cores. The Core A PI will meet with each of the project and core PI?s individually to discuss any impediments to progress and plans to address any if present. Core A will review each of the Projects and Core?s annual progress reports to NIH, and co-ordinate submission of the annual progress reports to the NIH.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
2U19AI070535-11
Application #
9154621
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2016-09-01
Budget End
2017-08-31
Support Year
11
Fiscal Year
2016
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Karta, Maya R; Rosenthal, Peter S; Beppu, Andrew et al. (2018) ?2 integrins rather than ?1 integrins mediate Alternaria-induced group 2 innate lymphoid cell trafficking to the lung. J Allergy Clin Immunol 141:329-338.e12
Mehta, A K; Doherty, T; Broide, D et al. (2018) Tumor necrosis factor family member LIGHT acts with IL-1? and TGF-? to promote airway remodeling during rhinovirus infection. Allergy 73:1415-1424
Doherty, Taylor A; Broide, David H (2018) Lipid regulation of group 2 innate lymphoid cell function: Moving beyond epithelial cytokines. J Allergy Clin Immunol 141:1587-1589
da Silva Antunes, Ricardo; Mehta, Amit K; Madge, Lisa et al. (2018) TNFSF14 (LIGHT) Exhibits Inflammatory Activities in Lung Fibroblasts Complementary to IL-13 and TGF-?. Front Immunol 9:576
Unno, Hirotoshi; Miller, Marina; Rosenthal, Peter et al. (2018) Activating transcription factor 6? (ATF6?) regulates airway hyperreactivity, smooth muscle proliferation, and contractility. J Allergy Clin Immunol 141:439-442.e4
Miller, Marina; Vuong, Christine; Garcia, Meghan Farrell et al. (2018) Does reduced zona pellucida binding protein 2 (ZPBP2) expression on chromosome 17q21 protect against asthma? J Allergy Clin Immunol 142:706-709.e4
Ordovas-Montanes, Jose; Dwyer, Daniel F; Nyquist, Sarah K et al. (2018) Allergic inflammatory memory in human respiratory epithelial progenitor cells. Nature 560:649-654
Herro, Rana; Shui, Jr-Wen; Zahner, Sonja et al. (2018) LIGHT-HVEM signaling in keratinocytes controls development of dermatitis. J Exp Med 215:415-422
Chen, Jun; Miller, Marina; Unno, Hirotoshi et al. (2018) Orosomucoid-like 3 (ORMDL3) upregulates airway smooth muscle proliferation, contraction, and Ca2+ oscillations in asthma. J Allergy Clin Immunol 142:207-218.e6
White, Andrew A; Doherty, Taylor A (2018) Role of group 2 innate lymphocytes in aspirin-exacerbated respiratory disease pathogenesis. Am J Rhinol Allergy 32:7-11

Showing the most recent 10 out of 106 publications